ReviewFrontiers in pharmacology2026

Paeoniflorin as a candidate disease-modifying therapy for diabetic peripheral neuropathy: mechanisms, exposure challenges, and translational priorities.

Yu-Ning Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.